LifeMD Non-GAAP EPS of -$0.25 beats by $0.01, revenue of $29M misses by $2.53M

• LifeMD press release (NASDAQ:LFMD): Q1 Non-GAAP EPS of -$0.25 beats by $0.01.
• Revenue of $29M (+59.3% Y/Y) misses by $2.53M.
• Q2 Outlook: Revenue to total between $31M and $33M vs. consensus of $34.6M; Adjusted EBITDA between $(5.5)M and $(6.5)M.
• FY2022 Outlook: Revenue to total between $132M and $138M vs. consensus of $144.95M; Adjusted EBITDA between $(14)M and $(20)M.